Latest News about SNY
Recent news which mentions SNY
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
April 14, 2022
Tickers
SNY
From Benzinga
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
Could This Drug Candidate Be a Blockbuster for Sanofi?
April 09, 2022
From Motley Fool
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
From Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
From Benzinga
From Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
March 30, 2022
From Benzinga
From Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
From Benzinga
Why Is IGM Biosciences (IGMS) Stock Up Today?
March 29, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
From Benzinga
Why IGM Biosciences Stock Rocketed Higher Today
March 29, 2022
From Motley Fool
From Benzinga
These 2 Stocks Are Up 20%-Plus in Tuesday's Premarket
March 29, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.